Bayer details R&D spending, names innovation projects

Bayer provided details last week of its 2012 R&D budget, including the split of expenditures among the company’s three subgroups: Bayer HealthCare, Bayer CropScience, and Bayer MaterialScience. Speaking at a press briefing, with the theme Bayer Perspective on Innovation, held last week in Leverkusen, Bayer chairman and CEO Marijn Dekkers said that the group’s R&D budget this year is €3 billion ($3.83 billion), “making it the largest budget in our industry in Germany.” The company says it submitted more than 600 patent...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers